Efficacy News and Research

RSS

Tocilizumab fails to affect COVID-19 disease outcomes in Boston trial

Researchers from the various Massachusetts hospitals performed the Boston Area COVID-19 Consortium (BACC) Bay Tocilizumab Trial using tocilizumab administered early in the disease course to determine if early IL-6 receptor blockade limits progression of COVID-19 to hypoxemic respiratory failure or death. Their work is published in the prestigious New England Journal of Medicine.

25 Oct 2020

Antenatal steroids improve preterm newborn survival in low-resource settings, finds study

The results of a new clinical trial, published today in the New England Journal of Medicine, show that dexamethasone- a glucocorticoid used to treat many conditions, including rheumatic problems and severe COVID-19- can boost survival of premature babies when given to pregnant women at risk of preterm birth in low-resource settings.

23 Oct 2020

Mathematical modeling study offers new insights into optimal timing of antiviral therapies against COVID-19

A new mathematical modeling study by Ashish Goyal and colleagues, informed by data collected from 25 patients hospitalized with COVID-19 in 4 different countries, offers some important new insights into the optimal timing of 4 different antiviral therapies to combat the disease.

23 Oct 2020

ACROBiosystems and the Fight Against COVID-19

In this interview, Dr. Yinang Jiang discusses ACROBiosystems and their efforts in the fight against COVID-19 and the search for a vaccine

From ACROBiosystems 23 Oct 2020

High-impact clinical trial results could improve kidney-related medical care

The results of numerous high-impact clinical trials that could affect kidney-related medical care will be presented online during ASN Kidney Week 2020 Reimagined October 19-October 25.

23 Oct 2020

Burt's Bees announces research data supporting the efficacy of natural lip and anti-aging skincare

Burt's Bees, a pioneer in natural skin care, today announced new research supporting the role of efficacy-first, natural regimens to defend, replenish and restore vibrant, healthier-looking skin.

23 Oct 2020

New research may shed light on challenges of developing universal flu vaccine

New research from an immunology team at the University of Chicago may shed light on the challenges of developing a universal flu vaccine that would provide long-lasting and broad protection against influenza viruses.

23 Oct 2020

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

U.S. Naval Research Laboratory researchers evaluated commercial ultraviolet (UV) sources for viral disinfection to combat COVID-19 on land and at sea, and established a dedicated UV characterization lab in five days to ensure safe introduction and effective operation of UV sources across the Fleet.

22 Oct 2020

First antiviral treatment for COVID-19 receives FDA approval

Today, the U.S. Food and Drug Administration approved the antiviral drug Veklury (remdesivir) for use in adult and pediatric patients 12 years of age and older and weighing at least 40 kilograms (about 88 pounds) for the treatment of COVID-19 requiring hospitalization.

22 Oct 2020

Common medication used to treat diabetic macular edema is less effective in Black patients

A medication frequently used to treat diabetic macular edema, which is the most common cause of blindness in people with diabetes, is less effective when used to treat the condition in Black patients, new study results show.

22 Oct 2020

Robotic Trunk Support Trainer helps children with cerebral palsy to sit more stably

Cerebral palsy (CP) is the most common childhood physical disability - 2.0-3.5 per 1000 births - and children born with it have impaired development and diminished control of movement and posture.

22 Oct 2020

Monoclonal Antibodies: Discovery, Characterization and Challenges

In this interview, News-Medical talks to David Apiyo, a senior manager of applications at Sartorius AG, about monoclonal antibody development and characterization.

22 Oct 2020

IBA doses do not benefit cycad propagation, shows study

The newly published thesis research of University of Guam Master of Environmental Science graduate Benjamin Deloso now adds to the body of knowledge about asexual propagation of the most endangered plant group in the world, cycads.

22 Oct 2020

Trump says he saved 2 million lives from COVID. Really?

President Donald Trump has repeatedly claimed to have saved 2 million lives from COVID-19 through his actions to combat the disease.

21 Oct 2020

Study analyzes the effect of political factors on COVID-19 vaccine acceptance among the public

If an initial COVID-19 vaccine is about as effective as a flu shot, uptake by the American public may fall far short of the 70% level needed to achieve herd immunity, new Cornell research suggests.

21 Oct 2020

Novel method can test the efficacy of antibacterial drugs on infectious microbes

A rapid and simple method for testing the efficacy of antibacterial drugs on infectious microbes has been developed and validated by a team of Penn State researchers.

21 Oct 2020

NIH awards $1.6 million for research on hormonal control of HIV latency

The National Institutes of Health has awarded $1.6 million to researchers at the George Washington University School of Medicine and Health Sciences for research on hormonal control of HIV latency.

20 Oct 2020

Scientists suggest that anti-malarial drugs could be repurposed to treat COVID-19

An international group of researchers believe there is enough evidence that anti-malarial drugs could be repurposed to treat COVID-19 and that they should be assessed for efficacy in clinical trials.

20 Oct 2020

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

When Terry Mutter woke up with a headache and sore muscles on a recent Wednesday, the competitive weightlifter chalked it up to a hard workout.

20 Oct 2020

Androgen deprivation strategies could help mitigate SARS-CoV-2 infection

Since the beginning of the COVID-19 pandemic, researchers have noted that women are generally less severely affected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This has led to the exploration into estrogen and androgens' role in the hyperinflammatory clinical phenotypes of COVID-19. A recent study published on the preprint server bioRxiv shows that drugs targeting androgens and TMPRSS2 inhibitors may potentially combat the pandemic.

20 Oct 2020

Efficacy News and Research

Tocilizumab fails to affect COVID-19 disease outcomes in Boston trial

Antenatal steroids improve preterm newborn survival in low-resource settings, finds study

Mathematical modeling study offers new insights into optimal timing of antiviral therapies against COVID-19

ACROBiosystems and the Fight Against COVID-19

High-impact clinical trial results could improve kidney-related medical care

Burt's Bees announces research data supporting the efficacy of natural lip and anti-aging skincare

New research may shed light on challenges of developing universal flu vaccine

Navy researchers evaluate commercial UV sources for viral disinfection to combat COVID-19

First antiviral treatment for COVID-19 receives FDA approval

Common medication used to treat diabetic macular edema is less effective in Black patients

Robotic Trunk Support Trainer helps children with cerebral palsy to sit more stably

Monoclonal Antibodies: Discovery, Characterization and Challenges

IBA doses do not benefit cycad propagation, shows study

Trump says he saved 2 million lives from COVID. Really?

Study analyzes the effect of political factors on COVID-19 vaccine acceptance among the public

Novel method can test the efficacy of antibacterial drugs on infectious microbes

NIH awards $1.6 million for research on hormonal control of HIV latency

Scientists suggest that anti-malarial drugs could be repurposed to treat COVID-19

Can ordinary COVID patients get the Trump treatment? It’s OK to ask

Androgen deprivation strategies could help mitigate SARS-CoV-2 infection

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News